Cita APA

Liu, L. Y., Strassner, J. P., Refat, M. A., Harris, J. E., & King, B. A. (2017). Repigmentation in vitiligo using the janus kinase inhibitor, tofacitinib, may require concomitant light exposure. J Am Acad Dermatol.

Citación estilo Chicago

Liu, Lucy Y., James P. Strassner, Maggi A. Refat, John E. Harris, y Brett A. King. "Repigmentation in Vitiligo Using the Janus Kinase Inhibitor, Tofacitinib, May Require Concomitant Light Exposure." J Am Acad Dermatol 2017.

Cita MLA

Liu, Lucy Y., et al. "Repigmentation in Vitiligo Using the Janus Kinase Inhibitor, Tofacitinib, May Require Concomitant Light Exposure." J Am Acad Dermatol 2017.